{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:38:07Z","timestamp":1789562287385,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":97,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101789","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:22:17Z","timestamp":1776295337000},"page":"101789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor \u03b21\/SMAD Signaling"],"prefix":"10.1016","volume":"20","author":[{"given":"Kihyoun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Woon","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bansi P.","family":"Savaliya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carys A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Pirius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3395-3689","authenticated-orcid":false,"given":"Kyoungsub","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101789_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101789_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101789_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.6000\/1927-7229.2012.01.01.7","article-title":"Challenges of cholangiocarcinoma detection in patients with primary sclerosing cholangitis","volume":"1","author":"Tabibian","year":"2012","journal-title":"J Anal Oncol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","author":"Alabraba","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jcmgh.2026.101789_bib5","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/gutjnl-2017-314249","article-title":"Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?","volume":"66","author":"O'Hara","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101789_bib6","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.31228","article-title":"Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice","volume":"72","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101789_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/00365521.2020.1787501","article-title":"Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis","volume":"55","author":"Ali","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/MEG.0000000000001223","article-title":"Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis","volume":"30","author":"de Chambrun","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib9","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1136\/bcr-2017-221165","article-title":"Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation","volume":"2017","author":"Hey","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jcmgh.2026.101789_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101789_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrgastro.2011.133","article-title":"The intestinal microbiota and chronic disorders of the gut","volume":"8","author":"DuPont","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101789_bib13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101789_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MOG.0000000000000334","article-title":"Intestinal microbiota in primary sclerosing cholangitis","volume":"33","author":"Hov","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib15","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","article-title":"Gut-microbiota-targeted diets modulate human immune status","volume":"184","author":"Wastyk","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jcmgh.2026.101789_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2019.108583","article-title":"Sugar reduction in bakery products: current strategies and sourdough technology as a potential novel approach","volume":"126","author":"Sahin","year":"2019","journal-title":"Food Res Int"},{"key":"10.1016\/j.jcmgh.2026.101789_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijfoodmicro.2021.109327","article-title":"Genomic analysis of Leuconostoc citreum TR116 with metabolic reconstruction and the effects of fructose on gene expression for mannitol production","volume":"354","author":"Sahin","year":"2021","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00052-16","article-title":"Microbial succession and flavor production in the fermented dairy beverage kefir","volume":"1","author":"Walsh","year":"2016","journal-title":"mSystems"},{"key":"10.1016\/j.jcmgh.2026.101789_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12935-023-02853-6","article-title":"In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer","volume":"23","author":"Ge","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jcmgh.2026.101789_bib20","first-page":"4","article-title":"Recreating gut-liver axis during NAFLD onset by using a Caco-2\/HepG2 co-culture system","volume":"2","author":"Meroni","year":"2022","journal-title":"Metabol Target Organ Damage"},{"key":"10.1016\/j.jcmgh.2026.101789_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108172","article-title":"Complex intestinal and hepatic in vitro barrier models reveal information on uptake and impact of micro-, submicro- and nanoplastics","volume":"179","author":"Paul","year":"2023","journal-title":"Environ Int"},{"key":"10.1016\/j.jcmgh.2026.101789_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fonc.2018.00357","article-title":"Transforming growth factor-\u03b2-induced cell plasticity in liver fibrosis and hepatocarcinogenesis","volume":"8","author":"Fabregat","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100512","article-title":"The phosphorylation of the Smad2\/3 linker region by nemo-like kinase regulates TGF-\u03b2 signaling","volume":"296","author":"Liang","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101789_bib24","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/liv.14453","article-title":"Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"40","author":"Adams","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2026.101789_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46404-5","article-title":"A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-\u03b2 signaling in hepatic stellate cells","volume":"13","author":"Kasahara","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101789_bib27","article-title":"Short-chain fatty acids in nonalcoholic fatty liver disease: new prospects for short-chain fatty acids as therapeutic targets","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jcmgh.2026.101789_bib28","article-title":"The gut microbiota-bile acid axis: a potential therapeutic target for liver fibrosis","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib29","first-page":"11","article-title":"Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease","volume":"7","author":"Zhou","year":"2021","journal-title":"Hepatoma Res"},{"issue":"4 Pt B","key":"10.1016\/j.jcmgh.2026.101789_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jcmgh.2026.101789_bib31","article-title":"Comparing animal well-being between bile duct ligation models","volume":"19","author":"Tang","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101789_bib32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4939-9420-5_16","article-title":"3,5-diethoxycarbonyl-1,4-dihydrocollidine diet: a rodent model in cholestasis research","volume":"1981","author":"Pose","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (PSC)","volume":"60","author":"Fickert","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1271\/bbb.110908","article-title":"Sinensetin attenuates LPS-induced inflammation by regulating the protein level of I\u03baB-\u03b1","volume":"76","author":"Shin","year":"2012","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.jcmgh.2026.101789_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2022.101866","article-title":"Sinensetin protects against pulmonary fibrosis via inhibiting Wnt\/\u03b2-Catenin signaling pathway","volume":"78","author":"Wan","year":"2022","journal-title":"Tissue Cell"},{"key":"10.1016\/j.jcmgh.2026.101789_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/645727","article-title":"Plumbagin ameliorates CCl 4 -induced hepatic fibrosis in rats via the epidermal growth factor receptor signaling pathway","volume":"2015","author":"Chen","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jcmgh.2026.101789_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113133","article-title":"Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats","volume":"151","author":"Pan","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcmgh.2026.101789_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.semarthrit.2019.11.009","article-title":"Beyond urate lowering: analgesic and anti-inflammatory properties of allopurinol","volume":"50","author":"Schlesinger","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jcmgh.2026.101789_bib39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000339078","article-title":"Allopurinol reverses liver damage induced by chronic carbon tetrachloride treatment by decreasing oxidative stress, TGF-\u03b2 production and NF-\u03baB nuclear translocation","volume":"92","author":"Aldaba-Muruato","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.jcmgh.2026.101789_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12866-020-02023-y","article-title":"Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells","volume":"20","author":"Ehrlich","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000538493","article-title":"Gut microbiota in primary sclerosing cholangitis: from prognostic role to therapeutic implications","volume":"42","author":"Maccauro","year":"2024","journal-title":"Dig Dis"},{"key":"10.1016\/j.jcmgh.2026.101789_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.jcmgh.2026.101789_bib43","doi-asserted-by":"crossref","first-page":"15.25.1","DOI":"10.1002\/0471142735.im1525s104","article-title":"Dextran sulfate sodium (DSS)-induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib44","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/s41467-023-39029-9","article-title":"Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis","volume":"14","author":"Ichikawa","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101789_bib45","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib46","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study","volume":"20","author":"Vleggaar","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gutjnl-2021-326500","article-title":"Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC","volume":"72","author":"Awoniyi","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2026.101789_bib48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"key":"10.1016\/j.jcmgh.2026.101789_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/ijms24010278","article-title":"Microarray expression profile of myricetin-treated THP-1 macrophages exhibits alterations in atherosclerosis-related regulator molecules and LXR\/RXR pathway","volume":"24","author":"Huwait","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101789_bib50","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1194\/jlr.M100358-JLR200","article-title":"LXR\/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells","volume":"43","author":"Murthy","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcmgh.2026.101789_bib51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10020-021-00283-6","article-title":"TGF-\u03b2-induced \u03b1-SMA expression is mediated by C\/EBP\u03b2 acetylation in human alveolar epithelial cells","volume":"27","author":"Ding","year":"2021","journal-title":"Mol Med"},{"key":"10.1016\/j.jcmgh.2026.101789_bib52","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0168-8278(03)00360-X","article-title":"Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats","volume":"39","author":"St\u00e4rkel","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101789_bib53","doi-asserted-by":"crossref","first-page":"G27","DOI":"10.1152\/ajpgi.00460.2001","article-title":"Modulatory effects of estrogen in two murine models of experimental colitis","volume":"283","author":"Verd\u00fa","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"Pt 2","key":"10.1016\/j.jcmgh.2026.101789_bib54","article-title":"Estrogen receptor \u03b1 aggravates intestinal inflammation via promoting the activation of NLRP3 inflammasome","volume":"143","author":"Gao","year":"2024","journal-title":"Int Immunopharmacol"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:13:37Z","timestamp":1784103217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26000676"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101789","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor \u03b21\/SMAD Signaling","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101789"}}